NIPER Raebareli, AstraZeneca partner to boost clinical trials

NIPER Raebareli and AstraZeneca India signed an MoU to strengthen India's clinical research capabilities, extending trials beyond metros to 25 emerging research sites. The collaboration, backed by the Department of Pharmaceuticals, aligns with Biopharma SHAKTI's goal of establishing 1,000 clinical trial sites nationwide, focusing on workforce training, site readiness, and documentation support.